<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1219" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1219/" /><meta name="ncbi_pagename" content="Simpson-Golabi-Behmel Syndrome Type 1 - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Simpson-Golabi-Behmel Syndrome Type 1 - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Simpson-Golabi-Behmel Syndrome Type 1" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/11/29" /><meta name="citation_author" content="Brian J Sajorda" /><meta name="citation_author" content="Christina X Gonzalez-Gandolfi" /><meta name="citation_author" content="Evan R Hathaway" /><meta name="citation_author" content="Jennifer M Kalish" /><meta name="citation_pmid" content="20301398" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1219/" /><meta name="citation_keywords" content="Glypican-3" /><meta name="citation_keywords" content="Glypican-4" /><meta name="citation_keywords" content="GPC3" /><meta name="citation_keywords" content="GPC4" /><meta name="citation_keywords" content="Simpson-Golabi-Behmel Syndrome Type 1" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Simpson-Golabi-Behmel Syndrome Type 1" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Brian J Sajorda" /><meta name="DC.Contributor" content="Christina X Gonzalez-Gandolfi" /><meta name="DC.Contributor" content="Evan R Hathaway" /><meta name="DC.Contributor" content="Jennifer M Kalish" /><meta name="DC.Date" content="2018/11/29" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1219/" /><meta name="description" content="Simpson-Golabi-Behmel syndrome type 1 (SGBS1) is characterized by pre- and postnatal macrosomia; distinctive craniofacial features (including macrocephaly, coarse facial features, macrostomia, macroglossia, and palatal abnormalities); and commonly, mild to severe intellectual disability with or without structural brain anomalies. Other variable findings include supernumerary nipples, diastasis recti / umbilical hernia, congenital heart defects, diaphragmatic hernia, genitourinary defects, and gastrointestinal anomalies. Skeletal anomalies can include vertebral fusion, scoliosis, rib anomalies, and congenital hip dislocation. Hand anomalies can include large hands and postaxial polydactyly. Affected individuals are at increased risk for embryonal tumors, including Wilms tumor, hepatoblastoma, adrenal neuroblastoma, gonadoblastoma, hepatocellular carcinoma, and medulloblastoma." /><meta name="og:title" content="Simpson-Golabi-Behmel Syndrome Type 1" /><meta name="og:type" content="book" /><meta name="og:description" content="Simpson-Golabi-Behmel syndrome type 1 (SGBS1) is characterized by pre- and postnatal macrosomia; distinctive craniofacial features (including macrocephaly, coarse facial features, macrostomia, macroglossia, and palatal abnormalities); and commonly, mild to severe intellectual disability with or without structural brain anomalies. Other variable findings include supernumerary nipples, diastasis recti / umbilical hernia, congenital heart defects, diaphragmatic hernia, genitourinary defects, and gastrointestinal anomalies. Skeletal anomalies can include vertebral fusion, scoliosis, rib anomalies, and congenital hip dislocation. Hand anomalies can include large hands and postaxial polydactyly. Affected individuals are at increased risk for embryonal tumors, including Wilms tumor, hepatoblastoma, adrenal neuroblastoma, gonadoblastoma, hepatocellular carcinoma, and medulloblastoma." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1219/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/sgbs/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1219/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8915F8DFC87B210000000001A700D2.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1219_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1219_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/rss/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/stsl/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1219_"><span class="title" itemprop="name">Simpson-Golabi-Behmel Syndrome Type 1</span></h1><p class="contrib-group"><span itemprop="author">Brian J Sajorda</span>, BA, <span itemprop="author">Christina X Gonzalez-Gandolfi</span>, BA, <span itemprop="author">Evan R Hathaway</span>, MS, LCGC, and <span itemprop="author">Jennifer M Kalish</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1219_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1219_ai__"><div class="contrib half_rhythm"><span itemprop="author">Brian J Sajorda</span>, BA<div class="affiliation small">Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania</div></div><div class="contrib half_rhythm"><span itemprop="author">Christina X Gonzalez-Gandolfi</span>, BA<div class="affiliation small">Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania</div></div><div class="contrib half_rhythm"><span itemprop="author">Evan R Hathaway</span>, MS, LCGC<div class="affiliation small">Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania</div></div><div class="contrib half_rhythm"><span itemprop="author">Jennifer M Kalish</span>, MD, PhD<div class="affiliation small">Children's Hospital of Philadelphia<br />Perelman School of Medicine<br />University of Pennsylvania<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@jhsilak" class="oemail">ude.pohc.liame@jhsilak</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 19, 2006</span>; Last Update: <span itemprop="dateModified">November 29, 2018</span>.</p><p><em>Estimated reading time: 26 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="sgbs.Summary" itemprop="description"><h2 id="_sgbs_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Simpson-Golabi-Behmel syndrome type 1 (SGBS1) is characterized by pre- and postnatal macrosomia; distinctive craniofacial features (including macrocephaly, coarse facial features, macrostomia, macroglossia, and palatal abnormalities); and commonly, mild to severe intellectual disability with or without structural brain anomalies. Other variable findings include supernumerary nipples, diastasis recti / umbilical hernia, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects, diaphragmatic hernia, genitourinary defects, and gastrointestinal anomalies. Skeletal anomalies can include vertebral fusion, scoliosis, rib anomalies, and congenital hip dislocation. Hand anomalies can include large hands and postaxial polydactyly. Affected individuals are at increased risk for embryonal tumors, including Wilms tumor, hepatoblastoma, adrenal neuroblastoma, gonadoblastoma, hepatocellular carcinoma, and medulloblastoma.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of SGBS1 is established in a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive findings and/or a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GPC3</i>, an intragenic or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>GPC3</i> that may include part or all of <i>GPC4</i>, or a large multiexon <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of <i>GPC4</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. The diagnosis is usually established in a female proband who has suggestive findings and a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variant in <i>GPC3</i>, an intragenic or whole-gene deletion of <i>GPC3</i> that may include part or all of <i>GPC4</i>, or a large multiexon duplication of <i>GPC4</i> identified by molecular genetic testing.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Prompt treatment of neonatal hypoglycemia and airway obstruction resulting from micrognathia and glossoptosis. Treatment of cleft lip and/or cleft palate or macroglossia and related feeding difficulties, obstructive sleep apnea, ophthalmologic issues, hearing loss, heart defects, urogenital abnormalities, skeletal abnormalities, and seizures in a standard fashion by appropriate pediatric specialists. Speech therapy as needed. Neurodevelopmental assessment to determine the need for special education, occupational therapy, and/or physical therapy.</p><p><i>Surveillance:</i> Screening for Wilms tumor and hepatoblastoma with abdominal ultrasound and serum AFP level every three months from time of diagnosis until age four years; renal ultrasound every three months from age four to seven years; no specific tumor screening protocol has been established for neuroblastoma, gonadoblastoma, or medulloblastoma. Annual (or as indicated) ophthalmologic and audiologic evaluations in childhood; sleep study if there are concerns about sleep disturbance or sleep apnea; routine monitoring of renal function if renal anomalies are present; evaluation for scoliosis at least annually or during periods of rapid growth; monitoring of serum glucose level in the neonatal period; monitoring of developmental progress at each visit through adolescence.</p><p><i>Evaluation of relatives at risk:</i> It is appropriate to clarify the genetic status of apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the <i>GPC3</i> or <i>GCP4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family in order to identify as early as possible those who would benefit from preventive measures, such as tumor surveillance in males.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Simpson-Golabi-Behmel syndrome type 1 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting the pathogenic variant in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Females who inherit the pathogenic variant will be carriers, although due to <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>, <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females may have manifestations of SGBS1. Males with SGBS1 will pass the pathogenic variant to all of their daughters and none of their sons. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible for families in which the pathogenic variant has been identified.</p></div></div><div id="sgbs.Diagnosis"><h2 id="_sgbs_Diagnosis_">Diagnosis</h2><p>Consensus clinical diagnostic criteria for Simpson-Golabi-Behmel syndrome type 1 (SGBS1) have not been established.</p><div id="sgbs.Suggestive_Findings"><h3>Suggestive Findings</h3><p>The diagnosis of SGBS1 <b>should be suspected</b> in males with the following findings:</p><ul><li class="half_rhythm"><div><b>Macrosomia</b> (weight or length &#x02265;95th percentile)</div></li><li class="half_rhythm"><div><b>Characteristic facial features</b></div><ul><li class="half_rhythm"><div>Widely spaced eyes, epicanthal folds, and downslanted palpebral fissures</div></li><li class="half_rhythm"><div>Redundant, furrowed skin over the glabella</div></li><li class="half_rhythm"><div>Wide nasal bridge and anteverted nares in infants; broad nose and coarsening of facial features in older individuals</div></li><li class="half_rhythm"><div>Macrocephaly with or without a prominent forehead</div></li><li class="half_rhythm"><div>Macrostomia (abnormally large mouth)</div></li><li class="half_rhythm"><div>Macroglossia (abnormally large tongue) with or without a midline groove in the lower lip and/or deep furrow in the middle of the tongue</div></li><li class="half_rhythm"><div>Cleft lip and/or submucous cleft palate (with a bifid uvula); high and narrow palate</div></li><li class="half_rhythm"><div>Small mandible (micrognathia) in neonates; macrognathia in older individuals</div></li></ul></li><li class="half_rhythm"><div><b>Multiple <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies</b> (see <a href="#sgbs.Clinical_Description">Clinical Description</a>)</div><ul><li class="half_rhythm"><div>Congenital heart disease</div></li><li class="half_rhythm"><div>Conduction defects (transient QT interval prolongation)</div></li><li class="half_rhythm"><div>Supernumerary nipples</div></li><li class="half_rhythm"><div>Diastasis recti / umbilical hernia</div></li><li class="half_rhythm"><div>Diaphragmatic hernia</div></li><li class="half_rhythm"><div>Renal dysplasia / nephromegaly</div></li><li class="half_rhythm"><div>Cryptorchidism/hypospadias in males</div></li><li class="half_rhythm"><div>Hand and feet anomalies (brachydactyly, cutaneous syndactyly, polydactyly)</div></li></ul></li></ul></div><div id="sgbs.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of SGBS1 <b>is established</b> in a male proband with suggestive findings and/or a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GPC3</i>, an intragenic or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>GPC3</i> that may include part or all of <i>GPC4</i>, or a large multiexon <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of <i>GPC4</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1219/table/sgbs.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figsgbsTmoleculargenetictestingusedin" rid-ob="figobsgbsTmoleculargenetictestingusedin">Table 1</a>).</p><p><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of SGBS1 <b>is usually established</b> in a female proband with suggestive findings and a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GPC3</i>, an intragenic or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>GPC3</i> that may include part or all of <i>GPC4</i>, or a large multiexon <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of <i>GPC4</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1219/table/sgbs.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figsgbsTmoleculargenetictestingusedin" rid-ob="figobsgbsTmoleculargenetictestingusedin">Table 1</a>).</p><p>Note: (1) Intragenic pathogenic <i>GPC4</i> variants have not been described in isolation and are usually an extension of a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> that includes <i>GPC3</i> [<a class="bk_pop" href="#sgbs.REF.vuillaume.2018.790">Vuillaume et al 2018</a>]; however, <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of exons 1-9 in <i>GPC4</i> without deletion or mutation of <i>GPC3</i> was found in the original family described by <a class="bk_pop" href="#sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen [1984]</a> in which no <i>GPC3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> had been identified [<a class="bk_pop" href="#sgbs.REF.waterson.2010.3179">Waterson et al 2010</a>]. (2) There are currently no reports of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in either <i>GPC3</i> or <i>GPC4</i>. (3) To date, <i>GPC3</i> remains the principal monogenic contributor to SGBS [<a class="bk_pop" href="#sgbs.REF.vuillaume.2018.790">Vuillaume et al 2018</a>].</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, concurrent or serial single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis, <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of SGBS1 is broad, individuals with the distinctive findings described in <a href="#sgbs.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#sgbs.Option_1">Option 1</a>), whereas those in whom the diagnosis of SGBS1 has not been considered are more likely to be diagnosed using genomic testing (see <a href="#sgbs.Option_2">Option 2</a>). Any molecular findings must be interpreted in the context of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's clinical presentation [<a class="bk_pop" href="#sgbs.REF.vuillaume.2018.790">Vuillaume et al 2018</a>].</p><div id="sgbs.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of SGBS1, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, <b><a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a></b>, or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>GPC3</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants. Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Note: Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletion on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted deletion/duplication analysis.</p><ul><li class="half_rhythm"><div class="half_rhythm">Sequence analysis of <i>GPC3</i> is performed first, followed by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm">If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, <b><a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis (CMA)</b>, which uses oligonucleotide or SNP arrays to detect genome-wide large deletions/duplications (including <i>GPC3</i> and <i>GPC4</i>) that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, may be considered next.</div><div class="half_rhythm"><b>Note:</b> (1) CMA cannot determine the location or orientation of a <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a>. (2) If a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or duplication is of sufficient size, fluorescence in situ hybridization (<a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>) can be used to test parental samples for inheritance of the deletion or duplication.</div></li></ul><p><b>A</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>GPC3</i>, <i>GPC4</i>, and other genes of interest (see <a href="#sgbs.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. A multigene panel may identify the genetic cause of the condition at a reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK1219/table/sgbs.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figsgbsTmoleculargenetictestingusedin" rid-ob="figobsgbsTmoleculargenetictestingusedin">Table 1</a>).</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="sgbs.Option_2"><h4>Option 2</h4><p>When the diagnosis of SGBS1 is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is the most commonly used genomic testing method; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <b><a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a></b> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="sgbs.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Simpson-Golabi-Behmel Syndrome Type 1 (SGBS1)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1219/table/sgbs.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sgbs.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of SGBS1 Attributed to Pathogenic Variants in Gene</th><th id="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="4" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr><tr><th headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></th><th headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th><th headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CMA&#x000a0;<sup>6</sup></th><th headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Karyotype</th></tr></thead><tbody><tr><td headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GPC3</i></td><td headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">70%&#x000a0;<sup>7</sup></td><td headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~55%&#x000a0;<sup>8</sup></td><td headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~43%&#x000a0;<sup>8,&#x000a0;9</sup></td><td headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>10</sup></td><td headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 individuals&#x000a0;<sup>11</sup></td></tr><tr><td headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GPC4</i></td><td headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td><td headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>12</sup></td><td headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>12</sup></td><td headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>10,&#x000a0;13</sup></td><td headers="hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_sgbs.T.molecular_genetic_testing_used_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sgbs.TF.1.1"><p class="no_margin">See <a href="/books/NBK1219/#sgbs.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="sgbs.TF.1.2"><p class="no_margin">See <a href="#sgbs.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="sgbs.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="sgbs.TF.1.4"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>5. </dt><dd><div id="sgbs.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="sgbs.TF.1.6"><p class="no_margin">Chromosomal microarray analysis (CMA) uses oligonucleotide or SNP arrays to detect genome-wide large deletions/duplications (including <i>GPC3</i> and <i>GPC4</i>) that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>. The ability to determine the size of the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> depends on the type of microarray used and the density of probes in the Xq26.2 regions.</p></div></dd><dt>7. </dt><dd><div id="sgbs.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#sgbs.REF.spencer.2016.272">Spencer et al [2016]</a></p></div></dd><dt>8. </dt><dd><div id="sgbs.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#sgbs.REF.vuillaume.2018.790">Vuillaume et al [2018]</a></p></div></dd><dt>9. </dt><dd><div id="sgbs.TF.1.9"><p class="no_margin">Gene-targeted methods will detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> up to whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions; however, breakpoints of large deletions and/or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of adjacent genes may not be determined. CMA testing is appropriate to define breakpoints of large deletions.</p></div></dd><dt>10. </dt><dd><div id="sgbs.TF.1.10"><p class="no_margin">A contiguous <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>GPC3</i> and <i>GPC4</i> has been identified in one family with SGBS1 [<a class="bk_pop" href="#sgbs.REF.veugelers.1998.1">Veugelers et al 1998</a>].</p></div></dd><dt>11. </dt><dd><div id="sgbs.TF.1.11"><p class="no_margin">Two females reported [<a class="bk_pop" href="#sgbs.REF.punnett.1994.391">Punnett 1994</a>, <a class="bk_pop" href="#sgbs.REF.pilia.1996.241">Pilia et al 1996</a>]</p></div></dd><dt>12. </dt><dd><div id="sgbs.TF.1.12"><p class="no_margin">Intragenic pathogenic <i>GPC4</i> variants have not been described in isolation and are usually an extension of a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> that includes <i>GPC3</i> [<a class="bk_pop" href="#sgbs.REF.spencer.2016.272">Spencer et al 2016</a>].</p></div></dd><dt>13. </dt><dd><div id="sgbs.TF.1.13"><p class="no_margin">Duplication of exons 1-9 in <i>GPC4</i> without <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or mutation of <i>GPC3</i> was found in the original family described by <a class="bk_pop" href="#sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen [1984]</a> in which no <i>GPC3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> had been identified [<a class="bk_pop" href="#sgbs.REF.waterson.2010.3179">Waterson et al 2010</a>].</p></div></dd></dl></div></div></div></div></div></div><div id="sgbs.Clinical_Characteristics"><h2 id="_sgbs_Clinical_Characteristics_">Clinical Characteristics</h2><div id="sgbs.Clinical_Description"><h3>Clinical Description</h3><div id="sgbs.Males"><h4>Males</h4><p>Simpson-Golabi-Behmel syndrome type 1 (SGBS1) is characterized by pre- and postnatal macrosomia, distinctive facies, and variable visceral, skeletal, and neurodevelopmental abnormalities.</p><p><b>Macrosomia.</b> Virtually all persons with SGBS1 have pre- and postnatal overgrowth. As with other macrosomic syndromes, hypoglycemia may be present in the neonatal period.</p><p><b>Macrocephaly.</b> See <a href="#sgbs.Suggestive_Findings">Suggestive Findings</a>.</p><p><b>Characteristic facies.</b> See <a href="#sgbs.Suggestive_Findings">Suggestive Findings</a>.</p><p><b>Eyes.</b> Esotropia, cataracts, and coloboma of the optic disc [<a class="bk_pop" href="#sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen 1984</a>] have been noted. Ocular nerve palsies and strabismus can occur.</p><p><b>Ears.</b> Minor ear abnormalities are frequent, most often preauricular tags, fistulas, ear lobule creases, and helical dimples. Conductive hearing loss has been described [<a class="bk_pop" href="#sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen 1984</a>].</p><p><b>Oropharynx.</b> Macroglossia is a characteristic feature. Other anomalies include various degrees of palatal clefting (including submucous cleft and bifid uvula), laryngeal cleft, and laryngeal web. Obstructive sleep apnea may be present. Silent aspiration leading to chronic respiratory infections and bronchiectasis has also been described [<a class="bk_pop" href="#sgbs.REF.glamuzina.2009.1464">Glamuzina et al 2009</a>, <a class="bk_pop" href="#sgbs.REF.tenorio.2014.138">Tenorio et al 2014</a>].</p><p><b>Neck.</b> Cystic hygroma has been described [<a class="bk_pop" href="#sgbs.REF.chen.1993.574">Chen et al 1993</a>].</p><p><b>Thoracoabdominal wall.</b> Supernumerary nipples are common, either one or multiple, unilateral or bilateral. Diastasis recti and umbilical hernias are observed frequently; however, true omphalocele is rare.</p><p><b>Cardiothoracic.</b> Congenital heart defects are variable; septal defects are common. Pulmonic stenosis, aortic coarctation, transposition of the great vessels, and patent ductus arteriosus or patent foramen ovale have been reported.</p><p>Conduction defects and arrhythmias have frequently been described [<a class="bk_pop" href="#sgbs.REF.lin.1999.378">Lin et al 1999</a>]. Transient QT interval prolongation has also been reported [<a class="bk_pop" href="#sgbs.REF.gertsch.2010.2379">Gertsch et al 2010</a>].</p><p><b>Lungs.</b> Abnormal branching of the bronchi and an abnormal lower airway pit have been described in one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual [<a class="bk_pop" href="#sgbs.REF.glamuzina.2009.1464">Glamuzina et al 2009</a>].</p><p><b>Genitourinary.</b> Nephromegaly, multicystic kidneys, hydronephrosis, hydroureter, and duplicated ureters are described. Other genitourinary anomalies include hypospadias, bifid scrotum, cryptorchidism, hydrocele, and inguinal hernia [<a class="bk_pop" href="#sgbs.REF.hughesbenzie.1996.227">Hughes-Benzie et al 1996</a>].</p><p><b>Gastrointestinal.</b> GI anomalies include pyloric ring, Meckel's diverticulum, intestinal malrotation [<a class="bk_pop" href="#sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen 1984</a>], hepatosplenomegaly, pancreatic hyperplasia of islets of Langerhans, choledochal cysts [<a class="bk_pop" href="#sgbs.REF.kim.1999.267">Kim et al 1999</a>], duplication of the pancreatic duct, and polysplenia.</p><p><b>Skeletal.</b> Skeletal anomalies can include vertebral fusion, scoliosis, pectus excavatum, rib anomalies (including cervical ribs), <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hip dislocation [<a class="bk_pop" href="#sgbs.REF.terespolsky.1995.329">Terespolsky et al 1995</a>], small sciatic notches, and flared iliac wings [<a class="bk_pop" href="#sgbs.REF.chen.1993.574">Chen et al 1993</a>]. Extra lumbar vertebrae, spina bifida occulta, coccygeal skin tag, and bony appendage have also been documented [<a class="bk_pop" href="#sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen 1984</a>].</p><p>Hand anomalies such as large hands, broad thumbs, and brachydactyly are common. Other findings include syndactyly, clinodactyly, and postaxial polydactyly. Striking index finger hypoplasia with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> abnormalities of the proximal phalanx have been reported [<a class="bk_pop" href="#sgbs.REF.day.2005.35">Day &#x00026; Fryer 2005</a>]. Nail dysplasia, hypoplasia (particularly of the index finger), and hypoconvexity are common.</p><p>Advanced bone age, including presence of ossified carpal bones in a newborn, has been described [<a class="bk_pop" href="#sgbs.REF.chen.1993.574">Chen et al 1993</a>].</p><p><b>Central nervous system (CNS).</b> Normal intelligence has been described, but mild to severe intellectual disability is common, with language delay being the most characteristic finding.</p><p>Neurologic manifestations are perhaps the most varied findings. Hypotonia and absent primitive reflexes, a high-pitched cry in neonates, seizures, and abnormal EEG have all been described. Hydrocephalus, epilepsy, and attention-deficit/hyperactivity disorder may also be present [<a class="bk_pop" href="#sgbs.REF.tenorio.2014.138">Tenorio et al 2014</a>].</p><p>CNS malformations include agenesis of the corpus callosum, Chiari malformation and hydrocephalus [<a class="bk_pop" href="#sgbs.REF.young.2006.139">Young et al 2006</a>], and aplasia of the cerebellar vermis.</p><p><b>Neoplasia.</b> An absolute incidence and relative risk for tumors has not been established; the embryonic tumor frequency in persons with SGBS1 is likely between 5% and 10%; however, these numbers are based on case reports [<a class="bk_pop" href="#sgbs.REF.lapunzina.1998.153">Lapunzina et al 1998</a>, <a class="bk_pop" href="#sgbs.REF.lin.1999.378">Lin et al 1999</a>]. At least six tumor types have been described [<a class="bk_pop" href="#sgbs.REF.lapunzina.1998.153">Lapunzina et al 1998</a>, <a class="bk_pop" href="#sgbs.REF.li.2001.161">Li et al 2001</a>, <a class="bk_pop" href="#sgbs.REF.lapunzina.2005.53">Lapunzina 2005</a>, <a class="bk_pop" href="#sgbs.REF.thomas.2012.2534">Thomas et al 2012</a>].</p><ul><li class="half_rhythm"><div>Wilms tumor (in 4 individuals)</div></li><li class="half_rhythm"><div>Hepatoblastoma (2)</div></li><li class="half_rhythm"><div>Adrenal neuroblastoma (1)</div></li><li class="half_rhythm"><div>Gonadoblastoma (1)</div></li><li class="half_rhythm"><div>Hepatocellular carcinoma (1)</div></li><li class="half_rhythm"><div>Medulloblastoma (1)</div></li></ul><p>See <a href="/books/n/gene/wilms-ov/">Wilms Tumor Overview</a>.</p><p><b>Other</b></p><ul><li class="half_rhythm"><div>Diaphragmatic hernia and associated lung hypoplasia [<a class="bk_pop" href="#sgbs.REF.chen.1993.574">Chen et al 1993</a>]. See <a href="/books/n/gene/cdh-ov/">Congenital Diaphragmatic Hernia Overview</a>.</div></li><li class="half_rhythm"><div>Thymic hypoplasia and generalized lymphoid atrophy [<a class="bk_pop" href="#sgbs.REF.chen.1993.574">Chen et al 1993</a>]</div></li></ul></div><div id="sgbs.Heterozygous_Females"><h4>Heterozygous Females</h4><p>Due to skewed <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>, <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females can have manifestations of SBGS including macrosomia, macrocephaly, widely spaced eyes, broad and upturned nasal tip with prominent columella, macrostomia, prominent chin, hypoplastic fingernails, coccygeal skin tag and bony appendage, extra lumbar and thoracic vertebrae, and accessory nipples [<a class="bk_pop" href="#sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen 1984</a>]. Tall stature, coarse facial features, and developmental delay have also been reported [<a class="bk_pop" href="#sgbs.REF.gertsch.2010.2379">Gertsch et al 2010</a>].</p><p>To date, eight <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females with clinical expression of SGBS1 have been reported [<a class="bk_pop" href="#sgbs.REF.schirwani.2019.243">Schirwani et al 2019</a>]. The molecular genetic causes in these eight females are as follows: heterozygous <i>GPC3</i> and <i>GPC4</i> <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> (3), <i>GPC3</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> (2), balanced X-<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> translocations (2), and a heterozygous <i>GPC3</i> duplication (1) [<a class="bk_pop" href="#sgbs.REF.punnett.1994.391">Punnett 1994</a>, <a class="bk_pop" href="#sgbs.REF.pilia.1996.241">Pilia et al 1996</a>, <a class="bk_pop" href="#sgbs.REF.yano.2011.466">Yano et al 2011</a>, <a class="bk_pop" href="#sgbs.REF.mujezinovi_.2016.99">Mujezinovi&#x00107; et al 2016</a>, <a class="bk_pop" href="#sgbs.REF.shimojima.2016.16033">Shimojima et al 2016</a>, <a class="bk_pop" href="#sgbs.REF.vaisfeld.2017.285">Vaisfeld et al 2017</a>, <a class="bk_pop" href="#sgbs.REF.schirwani.2019.243">Schirwani et al 2019</a>]. Although the <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation remains unknown, postnatal overgrowth, coarse facial features, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects, intellectual disability, and hernias appear to be common features [<a class="bk_pop" href="#sgbs.REF.schirwani.2019.243">Schirwani et al 2019</a>].</p><p>Two females with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>GPC3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> were reported to have two different types of cancer: one had a sero-papilliferous cystoadenoma, a low-grade ovarian carcinoma; the other had breast cancer [<a class="bk_pop" href="#sgbs.REF.gurrieri.2011.145">Gurrieri et al 2011</a>]. Information was not sufficient to exclude other possible genetic causes for breast/ovarian cancer in the family.</p></div></div><div id="sgbs.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>In a study of <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>, <a class="bk_pop" href="#sgbs.REF.mariani.2003.225">Mariani et al [2003]</a> determined that all deletions and single-nucleotide variants occurring in the eight <i>GPC3</i> exons result in loss of function with no phenotypic distinctions based on size or position of a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or <a class="def" href="/books/n/gene/glossary/def-item/single-nucleotide-variant/">single-nucleotide variant</a>.</p></div><div id="sgbs.Penetrance"><h3>Penetrance</h3><p>Penetrance in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females is unknown, but mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females have been reported. All males reported with a <i>GPC3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have had clinical findings of SGBS1.</p></div><div id="sgbs.Nomenclature"><h3>Nomenclature</h3><p>SGBS1 was initially described by <a class="bk_pop" href="#sgbs.REF.simpson.1975.18">Simpson et al [1975]</a>, with later accounts by <a class="bk_pop" href="#sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen [1984]</a> and <a class="bk_pop" href="#sgbs.REF.behmel.1984.409">Behmel et al [1984]</a>.</p><p>Terms no longer in use for SGBS:</p><ul><li class="half_rhythm"><div>Gigantism-dysplasia syndrome</div></li><li class="half_rhythm"><div>Encephalo-tropho-schisis syndrome</div></li><li class="half_rhythm"><div>Golabi-Rosen syndrome</div></li><li class="half_rhythm"><div>Simpson dysmorphia syndrome</div></li></ul></div><div id="sgbs.Prevalence"><h3>Prevalence</h3><p>The prevalence of SGBS1 is unknown; however, it is believed to be underdiagnosed due to the wide spectrum of clinical severity.</p></div></div><div id="sgbs.Genetically_Related_Allelic_Disorde"><h2 id="_sgbs_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No other phenotypes are known to be associated with pathogenic variants in <i>GPC3</i> and <i>GPC4</i>.</p></div><div id="sgbs.Differential_Diagnosis"><h2 id="_sgbs_Differential_Diagnosis_">Differential Diagnosis</h2><div id="sgbs.T.disorders_to_consider_in_the_diff" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of SGBS1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1219/table/sgbs.T.disorders_to_consider_in_the_diff/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sgbs.T.disorders_to_consider_in_the_diff_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features of the Differential Dignosis Disorder</th></tr><tr><th headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4" id="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/SGBS1</th><th headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4" id="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from SGBS1</th></tr></thead><tbody><tr><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Simpson-Golabi-Behmel syndrome type 2<br />(infantile lethal variant)<br />(OMIM <a href="https://omim.org/entry/300209" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300209</a>)</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>OFD1</i>,<br /><i>PIGA</i>&#x000a0;<sup>1</sup></td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Macrosomia</div></li><li class="half_rhythm"><div>Widely spaced eyes, epicanthal folds, downslanted palpebral fissures</div></li><li class="half_rhythm"><div>Redundant, furrowed skin over the glabella</div></li><li class="half_rhythm"><div>Wide nasal bridge &#x00026; anteverted nares in infants; broad nose &#x00026; coarse facial appearance in older individuals</div></li><li class="half_rhythm"><div>Macrocephaly</div></li><li class="half_rhythm"><div>Macrostomia</div></li><li class="half_rhythm"><div>Macroglossia</div></li><li class="half_rhythm"><div>Cleft lip &#x00026;/or submucous cleft palate (w/bifid uvula); high &#x00026; narrow palate</div></li><li class="half_rhythm"><div>Small mandible (micrognathia) in neonates; macrognathia in older individuals</div></li><li class="half_rhythm"><div>Multiple <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies</div></li></ul>
</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">More lethal form usually<br />associated w/hydrops fetalis&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bws/">Beckwith-Wiedemann syndrome</a><br />(BWS)</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 3</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 3</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Macrosomia</div></li><li class="half_rhythm"><div>Macroglossia</div></li><li class="half_rhythm"><div>Ear anomalies</div></li><li class="half_rhythm"><div>Diastasis recti</div></li><li class="half_rhythm"><div>Hypoglycemia</div></li><li class="half_rhythm"><div>Genitourinary malformations</div></li><li class="half_rhythm"><div>&#x02191; incidence of tumors</div></li></ul>
</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Appreciably different facial features (midface flattening in BWS; broader forehead in SGBS1)</div></li><li class="half_rhythm"><div>Absence of relative macrocephaly</div></li><li class="half_rhythm"><div>Absence of skeletal abnormalities</div></li><li class="half_rhythm"><div>Omphalocele</div></li><li class="half_rhythm"><div>Phenotype often less pronounced w/age (in SGBS1, characteristic features may not be present in infancy)</div></li><li class="half_rhythm"><div>Hemihypertrophy / lateralized overgrowth more common</div></li><li class="half_rhythm"><div>Individuals w/BWS are less tall &#x00026; less <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> &#x00026; have fewer visceral &#x00026; skeletal malformations.</div></li></ul>
</td></tr><tr><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sotos/">Sotos syndrome</a></td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NSD1</i></td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypertelorism</div></li><li class="half_rhythm"><div>Broad forehead</div></li><li class="half_rhythm"><div>Downslanting palpebral fissures</div></li><li class="half_rhythm"><div>Hypoglycemia</div></li></ul>
</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures are more common.&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Weaver syndrome<br />(see <a href="/books/n/gene/weaver/"><i>EZH2</i>-Related Overgrowth</a>)</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EZH2</i></td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Overgrowth</div></li><li class="half_rhythm"><div>Umbilical hernia</div></li><li class="half_rhythm"><div>Ear anomalies</div></li><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Advanced bone age</div></li><li class="half_rhythm"><div>Vertebral defects</div></li><li class="half_rhythm"><div>Hypertelorism</div></li></ul>
</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Flat occiput</div></li><li class="half_rhythm"><div>Deep horizontal chin crease</div></li><li class="half_rhythm"><div>Large ears</div></li><li class="half_rhythm"><div>Absence of downslanting palpebral fissures, dental malocclusion, &#x00026; central groove of lower lip (all characteristic of SGBS1&#x000a0;<sup>4</sup>)</div></li><li class="half_rhythm"><div>Psychomotor delay typically more prominent</div></li></ul>
</td></tr><tr><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bcns/">Nevoid basal cell carcinoma syndrome</a><br />(NBCCS, Gorlin syndrome)</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PTCH</i></td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Macrocephaly</div></li><li class="half_rhythm"><div>Coarse facial features</div></li><li class="half_rhythm"><div>Bifid ribs</div></li></ul>
</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Multiple jaw keratocysts frequently beginning in 2nd decade of life</div></li><li class="half_rhythm"><div>Basal cell carcinomas usually from 3rd decade onwards</div></li></ul>
</td></tr><tr><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fryns/">Fryns syndrome</a></td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Coarse facies</div></li><li class="half_rhythm"><div>Diaphragmatic hernia w/lung hypoplasia</div></li><li class="half_rhythm"><div>Cleft lip/palate</div></li><li class="half_rhythm"><div>Congenital heart defects</div></li><li class="half_rhythm"><div>Ear anomalies</div></li><li class="half_rhythm"><div>Macrostomia</div></li></ul>
</td><td headers="hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_sgbs.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hydrocephalus</div></li><li class="half_rhythm"><div>Micro-/retrognathia</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="sgbs.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#sgbs.REF.fauth.2016.392">Fauth et al [2016]</a></p></div></dd><dt>2. </dt><dd><div id="sgbs.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#sgbs.REF.tenorio.2014.138">Tenorio et al [2014]</a></p></div></dd><dt>3. </dt><dd><div id="sgbs.TF.2.3"><p class="no_margin">BWS is associated with abnormal regulation of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> transcription through <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> at one or both <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> domains on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15.5. Most alterations are postzygotic, but rare cases are due to deletions, duplications, or chromosome rearrangements affecting 11p15.5. Most individuals with BWS have no family history of BWS; approximately 5%-10% have a family history consistent with parent-of-origin <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> transmission.</p></div></dd><dt>4. </dt><dd><div id="sgbs.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#sgbs.REF.baujat.2005.4">Baujat et al [2005]</a></p></div></dd></dl></div></div></div><p><b>Other syndromes</b> that may share overlapping features:</p><ul><li class="half_rhythm"><div><b>Perlman syndrome</b> (OMIM <a href="https://omim.org/entry/267000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">267000</a>), a rare <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> condition caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>DIS3L2</i>, includes macrosomia and a high incidence of Wilms tumor; facial features are distinctive and neonatal mortality is high.</div></li><li class="half_rhythm"><div><b>Nevo syndrome,</b> an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> condition that shares vertebral anomalies, ear malformations, cryptorchidism, overgrowth, and intellectual disability with SGBS1. Nevo syndrome manifestations further include accelerated osseous maturation, large extremities, and hypotonia. This condition is caused by pathogenic variants in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 9 of <i>PLOD1</i> [<a class="bk_pop" href="#sgbs.REF.giunta.2005.158">Giunta et al 2005</a>]. (See <a href="/books/n/gene/eds6/">Ehlers-Danlos Syndrome, Kyphoscoliotic Form</a>.)</div></li><li class="half_rhythm"><div><b>Marshall-Smith syndrome</b> (OMIM <a href="https://omim.org/entry/602535" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">602535</a>), which shares advanced bone age and intellectual disability with SGBS1; differences include facial features and predisposition to fractures. This condition is caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>NFIX</i> and frequently occurs <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>.</div></li><li class="half_rhythm"><div><b>Elejalde syndrome</b> (acrocephalopolydactylous dysplasia) (OMIM <a href="https://omim.org/entry/256710" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">256710</a>). Infrequently described, Elejalde syndrome includes findings of macrosomia, abnormal facies, craniosynostosis with acrocephaly, omphalocele, organomegaly, cystic renal dysplasia, and polydactyly.</div></li><li class="half_rhythm"><div><b>Infant of a diabetic mother syndrome.</b> Infants born to diabetic mothers (IDM) have a higher rate of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> malformations. Sacral agenesis or hypogenesis and/or caudal dysgenesis are classic findings [<a class="bk_pop" href="#sgbs.REF.williamson.1970.145">Williamson 1970</a>], but other frequently observed anomalies include congenital heart defects, renal anomalies, vertebral anomalies, limb defects, and structural brain abnormalities.</div></li><li class="half_rhythm"><div><b>Mosaic trisomy 8.</b> Phenotype is variable, with characteristic findings of advanced growth, long slender trunk with multiple skeletal abnormalities (spinal deformities, contractures of fingers and toes), absence of the corpus callosum, and moderate intellectual disability. Typical facial features include high, prominent forehead, hypertelorism, full lips, and micrognathia.</div></li><li class="half_rhythm"><div><b>Mosaic tetrasomy 12p</b> (or Pallister-Killian syndrome), characterized by: variegated skin pigmentation; facial anomalies including prominent forehead with sparse anterior scalp hair, ocular hypertelorism, short nose with anteverted nares, and flat nasal bridge; and developmental delay</div></li></ul></div><div id="sgbs.Management"><h2 id="_sgbs_Management_">Management</h2><div id="sgbs.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with Simpson-Golabi-Behmel syndrome type 1 (SGBS1), the evaluations summarized in <a class="figpopup" href="/books/NBK1219/table/sgbs.T.recommended_evaluations_following/?report=objectonly" target="object" rid-figpopup="figsgbsTrecommendedevaluationsfollowing" rid-ob="figobsgbsTrecommendedevaluationsfollowing">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="sgbs.T.recommended_evaluations_following" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with Simpson-Golabi-Behmel Syndrome Type 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1219/table/sgbs.T.recommended_evaluations_following/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sgbs.T.recommended_evaluations_following_lrgtbl__"><table><thead><tr><th id="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Oropharynx</b></td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for macroglossia &#x00026; orofacial clefting.</td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to craniofacial team, incl feeding specialists</td></tr><tr><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic examination</td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ears/Hearing</b></td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Audiologic evaluation</td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac</b></td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider chest radiograph, EKG, &#x00026; echocardiogram.</td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for structural heart defects &#x00026; conduction abnormalities</td></tr><tr><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for upper-airway sufficiency &#x00026; signs/symptoms of sleep apnea; formal sleep study should be considered.</td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Particularly in those w/hypotonia &#x00026; macroglossia</td></tr><tr><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Renal</b></td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Examination for hypospadias &#x00026; undescended testes in males</td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Referral to urologist, as needed</td></tr><tr><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Renal ultrasound to assess for renal anomalies</td></tr><tr><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Abdomen/Pelvis</b></td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Abdominal/pelvic ultrasound to initiate tumor screening</td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Further studies (e.g., MRI) may be indicated if findings are suspicious for a tumor.</td></tr><tr><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Measurement of serum alpha fetoprotein</td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As a baseline screen for hepatoblastoma</td></tr><tr><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical evaluation for scoliosis</td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Particularly during times of rapid growth</td></tr><tr><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic evaluation, head MRI, &#x00026;/or EEG</td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If concerns for seizures</td></tr><tr><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Endocrinologic</b></td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment for hypoglycemia</td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In neonates</td></tr><tr><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl speech &#x00026; language assessment</td></tr><tr><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_sgbs.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div></div><div id="sgbs.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="sgbs.T.treatment_of_manifestations_in_in" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with Simpson-Golabi-Behmel Syndrome Type 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1219/table/sgbs.T.treatment_of_manifestations_in_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sgbs.T.treatment_of_manifestations_in_in_lrgtbl__"><table><thead><tr><th id="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Manifestation/Concern</th><th id="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Treatment</th><th id="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Macroglossia, micrognathia, &#x00026;/or glossoptosis</b></td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Prompt standard treatment to maintain a secure airway; consider feeding/swallowing evaluation.</td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May require care of a craniofacial team</td></tr><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cleft palate or bifid uvula</b></td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of feeding &#x00026; management by a cleft/craniofacial team</td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Obstructive sleep apnea (OSA)</b></td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If due to macroglossia, consider management similar to <a href="/books/n/gene/bws/">Beckwith-Wiedemann syndrome</a>.</td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Limited data are available on prevalence &#x00026; treatment of OSA in individuals w/SGBS1.</td></tr><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Sleep study &#x00026; potential CPAP or hemiglossectomy, if indicated</td></tr><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Feeding difficulties</b></td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Milder feeding issues may be managed w/special nipples or nasogastric feeding in consultation w/specialist.</td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Limited data are available on treatment of feeding difficulties in individuals w/SGBS1.</td></tr><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Gastrostomy tube may be considered in those w/severe feeding issues.</td></tr><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment for strabismus and cataracts</td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing</b></td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment for hearing loss</td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Congenital heart defects &#x00026; conduction abnormalities</b></td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment as per cardiologist</td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hypospadias/cryptorchidism in males</b></td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment as per urologist</td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal findings (i.e., scoliosis)</b></td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment as per orthopedist</td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Seizure disorder</b></td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment as per neurologist</td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hypoglycemia or suspected hyperinsulinism</b></td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Prompt treatment as per endocrinologist</td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to tertiary care center for hyperinsulinism evaluation, if suspected.</td></tr><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Developmental delay</b></td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early referral for developmental support/special education, which may incl physical therapy, occupational therapy, speech therapy, &#x00026;/or cognitive therapy</td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to a neurodevelopmental specialist &#x00026;/or neuropsychiatric testing.</td></tr><tr><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cancer predisposition</b></td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For Wilms tumor, nephron sparing surgery should be considered, if possible.</td><td headers="hd_h_sgbs.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="#sgbs.Surveillance">Surveillance</a> for the recommended tumor-screening protocol.</td></tr></tbody></table></div></div><div id="sgbs.Developmental_Delay__Intellectual_D"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="sgbs.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction.</b> Physical therapy is recommended to maximize mobility.</p><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy &#x02013; typically from an occupational or speech therapist &#x02013; is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties.</p></div></div><div id="sgbs.Surveillance"><h3>Surveillance</h3><div id="sgbs.T.recommended_surveillance_for_male" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Recommended Surveillance for Males with Simpson-Golabi-Behmel Syndrome Type 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1219/table/sgbs.T.recommended_surveillance_for_male/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sgbs.T.recommended_surveillance_for_male_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">System/Manifestation</th><th id="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Evaluation</th><th id="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Frequency/Comment</th></tr></thead><tbody><tr><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually in childhood or as indicated</td></tr><tr><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing</b></td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Audiologic evaluation</td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually in childhood or as indicated</td></tr><tr><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sleep study</td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If history of sleep disturbance</td></tr><tr><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Renal</b></td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Routine monitoring of renal function</td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If renal anomalies present</td></tr><tr><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate for scoliosis</td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At least annually or during periods of rapid growth</td></tr><tr><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Endocrine</b></td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor serum glucose levels for hypoglycemia secondary to increased risk for hyperinsulinemia.</td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neonatal period</td></tr><tr><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurodevelopment</b></td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor for developmental progress.</td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each clinic visit</td></tr><tr><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cancer</b><br /><b>predisposition</b></td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Tumor screening for Wilms tumors &#x00026; hepatoblastomas</td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Abdominal ultrasound &#x00026; serum AFP level every 3 mos from time of diagnosis until age 4 yrs</td></tr><tr><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_3" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Renal ultrasound every 3 mos from age 4-7 yrs</td></tr><tr><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Tumor screening for neuroblastoma &#x00026; gonadoblastoma</td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Insufficient data to determine utility of screening in individuals w/SGBS1</td></tr><tr><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Follow up w/cancer predisposition specialist &#x00026; physical examination</td><td headers="hd_h_sgbs.T.recommended_surveillance_for_male_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 6 mos&#x000a0;<sup>1</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sgbs.TF.5.1"><p class="no_margin"><a class="bk_pop" href="#sgbs.REF.kalish.2017.e115">Kalish et al [2017]</a></p></div></dd></dl></div></div></div><p>Little information on tumor risk in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females is available; there are currently only two reports of tumors in females with SGBS1 (see Clinical Description, <a href="#sgbs.Heterozygous_Females">Heterozygous Females</a>). However, screening can be considered in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females.</p></div><div id="sgbs.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the <i>GPC3</i> or <i>GCP4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family in order to identify as early as possible those who would benefit from preventive measures, such as tumor surveillance in males.</p><p>See <a href="#sgbs.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="sgbs.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="sgbs.Genetic_Counseling"><h2 id="_sgbs_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="sgbs.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Simpson-Golabi-Behmel syndrome type 1 (SGBS1) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div id="sgbs.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disorder nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the SBGS1-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, he does not require further testing.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> and may demonstrate some features of the condition. Note: If a woman has more than one affected child and no other affected relatives, and if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#sgbs.REF.romanelli.2007.384">Romanelli et al 2007</a>]. The frequency of germline mosaicism is currently unknown.</div></li><li class="half_rhythm"><div>If a male is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> or the affected male may have either a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GPC3</i>, a <i>de novo</i> intragenic or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>GPC3</i> that may include part or all of <i>GPC4</i>, or a <i>de novo</i> large multiexon <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of <i>GPC4</i>, in which case the mother is not a heterozygote. The frequency of <i>de novo</i> pathogenic variants is about 20%-30% [<a class="bk_pop" href="#sgbs.REF.tenorio.2014.138">Tenorio et al 2014</a>].</div></li></ul><p><b>Parents of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>A female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may have inherited the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from either her mother (who may or may not have manifestations of SBGS1) or her father [<a class="bk_pop" href="#sgbs.REF.st_ve.2017.608">St&#x000f8;ve et al 2017</a>], or the pathogenic variant may be <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>.</div></li><li class="half_rhythm"><div>Detailed evaluation of the parents and review of the extended family history may help distinguish probands with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from those with an inherited pathogenic variant. Molecular genetic testing of the mother (and possibly the father, or subsequently the father) may help determine whether the pathogenic variant was inherited.</div></li></ul><p><b>Sibs of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting the pathogenic variant in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the pathogenic variant will be heterozygotes and may be affected, as <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females with features of SGBS1 have been reported (see Clinical Description, <a href="#sgbs.Heterozygous_Females">Heterozygous Females</a>).</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Maternal germline mosaicism has been reported [<a class="bk_pop" href="#sgbs.REF.romanelli.2007.384">Romanelli et al 2007</a>].</div></li></ul><p><b>Sibs of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the parents:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a SGBS1-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the pathogenic variant will be heterozygotes and may be affected; <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females with features of SGBS1 have been reported (see Clinical Description, <a href="#sgbs.Heterozygous_Females">Heterozygous Females</a>).</div></li><li class="half_rhythm"><div>If the father of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, he will transmit it to all of his daughters and none of his sons. To date, one case of transmission from an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> father to his affected daughter has been reported [St&#x000f8;ve el al 2017].</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> (both maternal and paternal germline mosaicism have been reported in SGBS1 [<a class="bk_pop" href="#sgbs.REF.romanelli.2007.384">Romanelli et al 2007</a>, <a class="bk_pop" href="#sgbs.REF.agatep.2014.2682">Agatep et al 2014</a>]).</div></li></ul><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> To date, only one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male has been reported to reproduce; the affected male was only diagnosed after the fetal demise of the affected child [<a class="bk_pop" href="#sgbs.REF.st_ve.2017.608">St&#x000f8;ve et al 2017</a>].</p><p>Affected males transmit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to:</p><ul><li class="half_rhythm"><div>All of their daughters, who will be heterozygotes and may be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females with features of SGBS1 have been reported (see Clinical Description, <a href="#sgbs.Heterozygous_Females">Heterozygous Females</a>).</div></li><li class="half_rhythm"><div>None of their sons.</div></li></ul><p><b>Offspring of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Women with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a 50% chance of transmitting the pathogenic variant to each child:</p><ul><li class="half_rhythm"><div>Males who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li><li class="half_rhythm"><div>Females who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be heterozygotes (carriers) and may be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females with features of SGBS1 have been reported (see Clinical Description, <a href="#sgbs.Heterozygous_Females">Heterozygous Females</a>).</div></li></ul><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal aunts may be at risk of being heterozygotes for the <i>GPC3</i> and/or <i>GPC4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, and the aunts' offspring may be at risk of being having the pathogenic variant and being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p>Note: Molecular genetic testing may be able to identify the family member in whom a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> arose, information that could help determine genetic risk status of the extended family.</p></div><div id="sgbs.Heterozygote_Detection"><h3>Heterozygote Detection</h3><p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p>Note: (1) Females who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder may be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; heterozygous females with features of SGBS1 have been reported (see Clinical Description, <a href="#sgbs.Heterozygous_Females">Heterozygous Females</a>). (2) Identification of female heterozygotes requires either (a) prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family or, (b) if an affected male is not available for testing, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> first by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, and if no pathogenic variant is identified, by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p><p>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has not been identified in the family, physical examination of at-risk female relatives and <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> studies to determine if skewing of X-chromosome inactivation is present may identify some possible heterozygotes [Author, personal observation].</p></div><div id="sgbs.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#sgbs.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of at-risk females, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or are heterozygotes, or are at risk of being heterozygotes.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="sgbs.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the SGBS1-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>In pregnancies in which SGBS1 is suspected because of fetal overgrowth or <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies, the use of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (including <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> and <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>) can aid in diagnosis [<a class="bk_pop" href="#sgbs.REF.kehrer.2016.961">Kehrer et al 2016</a>].</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="sgbs.Resources"><h2 id="_sgbs_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/simpson-golabi-behmel-syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Simpson-Golabi-Behmel syndrome</a></div></li></ul></div><div id="sgbs.Molecular_Genetics"><h2 id="_sgbs_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="sgbs.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Simpson-Golabi-Behmel Syndrome Type 1: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1219/table/sgbs.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sgbs.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_sgbs.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_sgbs.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_sgbs.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_sgbs.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_sgbs.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_sgbs.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_sgbs.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2719" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GPC3</i></a></td><td headers="hd_b_sgbs.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2719" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq26<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_sgbs.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P51654" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Glypican-3</a></td><td headers="hd_b_sgbs.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/GPC3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GPC3 database</a></td><td headers="hd_b_sgbs.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GPC3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GPC3</a></td><td headers="hd_b_sgbs.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GPC3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GPC3</a></td></tr><tr><td headers="hd_b_sgbs.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2239" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GPC4</i></a></td><td headers="hd_b_sgbs.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2239" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq26<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_sgbs.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O75487" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Glypican-4</a></td><td headers="hd_b_sgbs.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/GPC4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GPC4 @ LOVD</a></td><td headers="hd_b_sgbs.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GPC4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GPC4</a></td><td headers="hd_b_sgbs.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GPC4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GPC4</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="sgbs.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="sgbs.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Simpson-Golabi-Behmel Syndrome Type 1 (<a href="/omim/300037,300168,312870" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1219/table/sgbs.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sgbs.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300037" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300037</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GLYPICAN 3; GPC3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300168" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300168</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GLYPICAN 4; GPC4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/312870" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">312870</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; SGBS1</td></tr></tbody></table></div></div><div id="sgbs.Introduction"><h3>Introduction</h3><p><i>GPC3</i> and <i>GPC4</i> both encode glycosylphosphatidylinositol-linked cell surface heparan sulfate proteoglycans, which belong to the glypican family. Heparan sulfate proteoglycans bind and regulate the activities of a variety of extracellular ligands essential to cellular functions. Glypicans have a role in cell growth and cell division. Abnormal glypican function may affect pathways such as Wnt signaling, Hedgehog pathway, BMP signaling, and FGF signaling [<a class="bk_pop" href="#sgbs.REF.painesaunders.2000.179">Paine-Saunders et al 2000</a>, <a class="bk_pop" href="#sgbs.REF.song.2005.2116">Song et al 2005</a>, <a class="bk_pop" href="#sgbs.REF.ng.2009.208">Ng et al 2009</a>].</p></div><div id="sgbs.GPC3"><h3><i>GPC3</i></h3><p><b>Gene structure.</b>
<i>GPC3</i> comprises eight exons that span more than 500 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1219/#sgbs.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> All eight exons of <i>GPC3</i> have been found to harbor deletions, duplications, or single-nucleotide variants that lead to the Simpson-Golabi-Behmel syndrome type 1 (SGBS1) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. The majority of SGBS1 cases are attributable to <i>GPC3</i>.</p><p>In a review of 120 persons with SGBS1 caused by 86 pathogenic variants in <i>GPC3</i>, large deletions were the most common (34.9%), then frameshifts (24.4%), <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants (16.3%), <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants (8.1%), large duplications (8.1%), <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants (4.7%), translocations (2.3%), and one <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/indel/">indel</a> (1.2%) [<a class="bk_pop" href="#sgbs.REF.vuillaume.2018.790">Vuillaume et al 2018</a>].</p><p>Approximately 50% of <i>GPC3</i> deletions involve <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 8 [<a class="bk_pop" href="#sgbs.REF.veugelers.2000.1321">Veugelers et al 2000</a>]. Single-nucleotide variants have been described in all exons; as expected, most occur in exon 3, the largest exon.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Glypican-3 is a glycosylphosphatidylinositol-linked cell surface heparan sulfate proteoglycan [<a class="bk_pop" href="#sgbs.REF.pilia.1996.241">Pilia et al 1996</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mechanism by which a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> <i>GPC3</i> variant leads to the SGBS1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is unknown. <a class="bk_pop" href="#sgbs.REF.yano.2011.466">Yano et al [2011]</a> reported that at least 43% loss of functional <i>GPC3</i> protein is required to develop the SGBS1 phenotype in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females (total detection rate is unknown) [<a class="bk_pop" href="#sgbs.REF.yano.2011.466">Yano et al 2011</a>].</p></div><div id="sgbs.GPC4"><h3><i>GPC4</i></h3><p><b>Gene structure.</b>
<i>GPC4</i> is adjacent to the 3' end of <i>GPC3</i> and comprises nine exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1219/#sgbs.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Duplication of exons 1-9 of <i>GPC4</i>
<b>without</b> a <i>GPC3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> also leads to the SGBS1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#sgbs.REF.waterson.2010.3179">Waterson et al 2010</a>]. Note: Loss-of-function variants in <i>GPC4</i> are <b>not</b> associated with SGBS1 [<a class="bk_pop" href="#sgbs.REF.veugelers.2000.1321">Veugelers et al 2000</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Glypican-4 is also a glycosylphosphatidylinositol-linked cell surface heparan sulfate proteoglycan [<a class="bk_pop" href="#sgbs.REF.veugelers.1998.1">Veugelers et al 1998</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mechanism by which <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of <i>GPC4</i> leads to the SGBS1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is unknown.</p></div><div id="sgbs.GPC3GPC4_Complex_Deletions_and_Dupl"><h3><i>GPC3/GPC4</i> Complex Deletions and Duplications</h3><p><b>Deletion.</b>
<a class="bk_pop" href="#sgbs.REF.dimaio.2017.147">DiMaio et al [2017]</a> reported a <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> case of SGBS1 caused by <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>GPC3</i>, <i>TFDP3</i>, <b>and</b>
<i>GPC4. TFDP3</i> (OMIM <a href="https://omim.org/entry/300772" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300772</a>) encodes a member of the DP family of transcription factors, but has no known disease association [<a class="bk_pop" href="#sgbs.REF.dimaio.2017.147">DiMaio et al 2017</a>].</p><p><b>Duplication.</b> Males and female carriers with complex <i>GPC3</i> and <i>GPC4</i> duplications have been reported [<a class="bk_pop" href="#sgbs.REF.schirwani.2019.243">Schirwani et al 2019</a>]. Additional atypical SGBS1 features, such as brain malformations, have been noted in these patients with the dual <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a>, suggesting that the new features may be associated with the <i>GPC4</i> duplication [<a class="bk_pop" href="#sgbs.REF.mujezinovi_.2016.99">Mujezinovi&#x00107; et al 2016</a>]. <a class="bk_pop" href="#sgbs.REF.mujezinovi_.2016.99">Mujezinovi&#x00107; et al [2016]</a> suggest that the <i>GPC4</i> duplication could cause a greater disruption of GPC3 expression, altering the phenotypic expression [<a class="bk_pop" href="#sgbs.REF.mujezinovi_.2016.99">Mujezinovi&#x00107; et al 2016</a>].</p><p>The mechanism by which <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of <i>GPC3</i> and <i>GPC4</i> leads to the SGBS1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is unknown. <a class="bk_pop" href="#sgbs.REF.schirwani.2019.243">Schirwani et al [2019]</a> reported two <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females with 45%-56% of the active X-<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a>-containing complex <i>GPC3/GPC4</i> duplications. These females manifested mild SGBS1 features including intellectual disability and developmental delay [<a class="bk_pop" href="#sgbs.REF.schirwani.2019.243">Schirwani et al 2019</a>].</p></div></div><div id="sgbs.References"><h2 id="_sgbs_References_">References</h2><div id="sgbs.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.agatep.2014.2682">Agatep R, Shuman C, Steele L, Parkinson N, Weksberg R, Stockley TL. Paternal germline mosaicism for a GPC3 deletion in X-linked Simpson-Golabi-Behmel syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2014;<span class="ref-vol">164A</span>:2682–4.</span> [<a href="/pubmed/25073799" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25073799</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.baujat.2005.4">Baujat G, Rio M, Rossignol S, Sanlaville D, Lyonnet S, Merrer ML, Munnich A, Gicquel C, Colleaux L, Cormier-Daire V. Clinical and molecular overlap in overgrowth syndromes. <span><span class="ref-journal">Am J Med Genet Part C Semin Med Genet. </span>2005;<span class="ref-vol">137C</span>:4–11.</span> [<a href="/pubmed/16010674" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16010674</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.behmel.1984.409">Behmel A, Plochl E, Rosenkranz W. A new X-linked dysplasia gigantism syndrome: identical with the Simpson dysplasia syndrome? <span><span class="ref-journal">Hum Genet. </span>1984;<span class="ref-vol">67</span>:409–13.</span> [<a href="/pubmed/6490008" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6490008</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.chen.1993.574">Chen E, Johnson JP, Cox VA, Golabi M. Simpson-Golabi-Behmel syndrome: congenital diaphragmatic hernia and radiologic findings in two patients and follow-up of a previously reported case. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">46</span>:574–8.</span> [<a href="/pubmed/8322824" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8322824</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.day.2005.35">Day R, Fryer A. Index finger abnormalities in Simpson-Golabi-Behmel syndrome. <span><span class="ref-journal">Clin Dysmorphol. </span>2005;<span class="ref-vol">14</span>:35–6.</span> [<a href="/pubmed/15602092" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15602092</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.dimaio.2017.147">DiMaio M, Yang H, Mahoney M, McGrath J, Li P. Familial GPC3 and GPC4-TFDP3 deletions at Xq26 associated with Simpson-Golabi-Behmel syndrome. <span><span class="ref-journal">Meta Gene. </span>2017;<span class="ref-vol">11</span>:147–51.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.fauth.2016.392">Fauth C, Steindl K, Toutain A, Farrell S, Witsch-Baumgartner M, Karall D, Joset P, B&#x000f6;hm S, Baumer A, Maier O, Zschocke J, Weksberg R, Marshall CR, Rauch A. A recurrent germline mutation in the PIGA gene causes Simpson-Golabi-Behmel syndrome type 2. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170A</span>:392–402.</span> [<a href="/pubmed/26545172" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26545172</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.glamuzina.2009.1464">Glamuzina E, Aftimos S, Keesing M, Mahadevan M. New airway and swallow manifestations of Simpson-Golabi-Behmel syndrome. <span><span class="ref-journal">Int J Pediatr Otorhinolaryngol. </span>2009;<span class="ref-vol">73</span>:1464–6.</span> [<a href="/pubmed/19631996" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19631996</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.gertsch.2010.2379">Gertsch E, Kirmani S, Ackerman MJ, Babovic-Vuksanovic D. Transient QT interval prolongation in an infant with Simpson&#x02013;Golabi&#x02013;Behmel syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2010;<span class="ref-vol">152A</span>:2379–82.</span> [<a href="/pmc/articles/PMC3332551/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3332551</span></a>] [<a href="/pubmed/20683991" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20683991</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.giunta.2005.158">Giunta C, Randolph A, Al-Gazali LI, Brunner HG, Kraenzlin ME, Steinmann B. Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers-Danlos syndrome (EDS VIA). <span><span class="ref-journal">Am J Med Genet. </span>2005;<span class="ref-vol">133A</span>:158–64.</span> [<a href="/pubmed/15666309" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15666309</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.golabi.1984.345">Golabi M, Rosen L. A new X-linked mental retardation-overgrowth syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1984;<span class="ref-vol">17</span>:345–58.</span> [<a href="/pubmed/6538755" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6538755</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.gurrieri.2011.145">Gurrieri F, Pomponi MG, Pietrobono R, Lucci-Cordisco E, Silvestri E, Storniello G, Neri G. The Simpson-Golabi-Behmel syndrome: a clinical case and a detective story. <span><span class="ref-journal">Am J Med Genet. </span>2011;<span class="ref-vol">155A</span>:145–8.</span> [<a href="/pubmed/21204223" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21204223</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.hughesbenzie.1996.227">Hughes-Benzie RM, Pilia G, Xuan JY, Hunter AG, Chen E, Golabi M, Hurst JA, Kobori J, Marymee K, Pagon RA, Punnett HH, Schelley S, Tolmie JL, Wohlferd MM, Grossman T, Schlessinger D, MacKenzie AE. Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">66</span>:227–34.</span> [<a href="/pubmed/8958336" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8958336</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.kalish.2017.e115">Kalish JM, Doros L, Helman LJ, Henneka RC, Kuiper RP, Maas SM, Maher ER, Nichols KE, Plon SE, Porter CC, Rednam S, Schultz KAP, States LJ, Tomlinson GE, Zelley K, Druley TE. Surveillance recommendations for children with overgrowth syndromes and predisposition to Wilms tumors and hepatoblastoma. <span><span class="ref-journal">Clin Cancer Res. </span>2017;<span class="ref-vol">23</span>:e115–22.</span> [<a href="/pmc/articles/PMC5538793/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5538793</span></a>] [<a href="/pubmed/28674120" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28674120</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.kehrer.2016.961">Kehrer C, Hoischen A, Menkhaus R, Schwab E, M&#x000fc;ller A, Kim S, Krei&#x000df; M, Weitensteiner V, Hilger A, Berg C, Geipel A, Reutter H, Gembruch U. Whole exome sequencing and array-based molecular karyotyping as aids to prenatal diagnosis in fetuses with suspected Simpson&#x02013;Golabi&#x02013;Behmel syndrome. <span><span class="ref-journal">Prenat Diagn. </span>2016;<span class="ref-vol">36</span>:961–5.</span> [<a href="/pubmed/27589329" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27589329</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.kim.1999.267">Kim S, Idowu O, Chen E. Choledochal cyst in Simpson-Golabi-Behmel syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1999;<span class="ref-vol">87</span>:267–70.</span> [<a href="/pubmed/10564884" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10564884</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.lapunzina.2005.53">Lapunzina P. Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2005;<span class="ref-vol">137C</span>:53–71.</span> [<a href="/pubmed/16010678" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16010678</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.lapunzina.1998.153">Lapunzina P, Badia I, Galoppo C, De Matteo E, Silberman P, Tello A, Grichener J, Hughes-Benzie R. A patient with Simpson-Golabi-Behmel syndrome and hepatocellular carcinoma. <span><span class="ref-journal">J Med Genet. </span>1998;<span class="ref-vol">35</span>:153–6.</span> [<a href="/pmc/articles/PMC1051222/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1051222</span></a>] [<a href="/pubmed/9507397" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9507397</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.li.2001.161">Li M, Shuman C, Fei YL, Cutiongco E, Bender HA, Stevens C, Wilkins-Haug L, Day-Salvatore D, Yong SL, Geraghty MT, Squire J, Weksberg R. GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">102</span>:161–8.</span> [<a href="/pubmed/11477610" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11477610</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.lin.1999.378">Lin AE, Neri G, Hughes-Benzie R, Weksberg R. Cardiac anomalies in the Simpson-Golabi-Behmel syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1999;<span class="ref-vol">83</span>:378–81.</span> [<a href="/pubmed/10232747" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10232747</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.mariani.2003.225">Mariani S, Iughetti L, Bertorelli R, Coviello D, Pellegrini M, Forabosco A, Bernasconi S. Genotype/phenotype correlations of males affected by Simpson-Golabi-Behmel syndrome with GPC3 gene mutations: patient report and review of the literature. <span><span class="ref-journal">J Pediatr Endocrinol Metab. </span>2003;<span class="ref-vol">16</span>:225–32.</span> [<a href="/pubmed/12713262" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12713262</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.mujezinovi_.2016.99">Mujezinovi&#x00107; F, Krgovic D, Blatnik A, Zagradisnik B, Vipotnik T, Golec T, Tul N, Vokac N. Simpson-Golabi-Behmel syndrome: a prenatal diagnosis in a foetus with GPC3 and GPC4 gene microduplications. <span><span class="ref-journal">Clin Genet. </span>2016;<span class="ref-vol">90</span>:99–101.</span> [<a href="/pubmed/26847959" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26847959</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.ng.2009.208">Ng A, Wong M, Viviano B, Erlich JM, Alba G, Pflederer C, Jay PY, Saunders S. Loss of glypican-3 function causes growth factor-dependent defects in cardiac and coronary vascular development. <span><span class="ref-journal">Dev Biol. </span>2009;<span class="ref-vol">335</span>:208–15.</span> [<a href="/pmc/articles/PMC2763964/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2763964</span></a>] [<a href="/pubmed/19733558" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19733558</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.painesaunders.2000.179">Paine-Saunders S, Viviano BL, Zupicich J, Skarnes WC, Saunders S. Glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development. <span><span class="ref-journal">Dev Biol. </span>2000;<span class="ref-vol">225</span>:179–87.</span> [<a href="/pubmed/10964473" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10964473</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.pilia.1996.241">Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. <span><span class="ref-journal">Nat Genet. </span>1996;<span class="ref-vol">12</span>:241–7.</span> [<a href="/pubmed/8589713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8589713</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.punnett.1994.391">Punnett HH. Simpson-Golabi-Behmel syndrome (SGBS) in a female with an X-autosome translocation. <span><span class="ref-journal">Am J Med Genet. </span>1994;<span class="ref-vol">50</span>:391–3.</span> [<a href="/pubmed/8209925" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8209925</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.romanelli.2007.384">Romanelli V, Arroyo I, Rodriguez JI, Magano L, Arias P, Incera I, Gracia-Bouthelier R, Lapunzina P. Germinal mosaicism in Simpson-Golabi-Behmel syndrome. <span><span class="ref-journal">Clin Genet. </span>2007;<span class="ref-vol">72</span>:384–6.</span> [<a href="/pubmed/17850639" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17850639</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.schirwani.2019.243">Schirwani S, Novelli A, Digilio M, Bourn D, Wilson V, Roberts C, Dallapiccola B, Hobson E. Duplications of GPC3 and GPC4 genes in symptomatic female carriers of Simpson-Golabi-Behmel syndrome type 1. <span><span class="ref-journal">Eur J Med Genet. </span>2019;<span class="ref-vol">62</span>:243–7.</span> [<a href="/pubmed/30048822" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30048822</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.shimojima.2016.16033">Shimojima K, Ondo Y, Nishi E, Mizuno S, Ito M, Ioi A, Shimizu M, Sato M, Inoue M, Okamoto N, Yamamoto T. Loss-of-function mutations and global rearrangements in GPC3 in patients with Simpson&#x02013;Golabi&#x02013;Behmel syndrome. <span><span class="ref-journal">Hum Genome Var. </span>2016;<span class="ref-vol">3</span>:16033.</span> [<a href="/pmc/articles/PMC5061924/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5061924</span></a>] [<a href="/pubmed/27790374" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27790374</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.simpson.1975.18">Simpson JL, Landey S, New M, German J. A previously unrecognized X-linked syndrome of dysmorphia. <span><span class="ref-journal">Birth Defects Orig Artic Ser. </span>1975;<span class="ref-vol">11</span>:18–24.</span> [<a href="/pubmed/1227524" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1227524</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.song.2005.2116">Song HH, Shi W, Xiang YY, Filmus J. The loss of glypican-3 induces alterations in Wnt signaling. <span><span class="ref-journal">J Biol Chem. </span>2005;<span class="ref-vol">280</span>:2116–25.</span> [<a href="/pubmed/15537637" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15537637</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.spencer.2016.272">Spencer C, Fieggen K, Vorster A, Beighton P. A clinical and molecular investigation of two South African families with Simpson-Golabi-Behmel syndrome. <span><span class="ref-journal">S Afr Med J. </span>2016;<span class="ref-vol">106</span>:272–5.</span> [<a href="/pubmed/26915941" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26915941</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.st_ve.2017.608">St&#x000f8;ve HK, Becher N, Gj&#x000f8;rup V, Ramsin M, Vogel I, Vestergaard EM. First reported case of Simpson&#x02013;Golabi&#x02013;Behmel syndrome in a female fetus diagnosed prenatally with chromosomal microarray. <span><span class="ref-journal">Clin Case Rep. </span>2017;<span class="ref-vol">5</span>:608–12.</span> [<a href="/pmc/articles/PMC5412752/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5412752</span></a>] [<a href="/pubmed/28469860" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28469860</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.tenorio.2014.138">Tenorio J, Arias P, Mart&#x000ed;nez-Glez V, Santos F, Garc&#x000ed;a-Mi&#x000f1;aur S, Nevado J, Lapunzina P. Simpson-Golabi-Behmel syndrome types I and II. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2014;<span class="ref-vol">9</span>:138.</span> [<a href="/pmc/articles/PMC4254265/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4254265</span></a>] [<a href="/pubmed/25238977" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25238977</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.terespolsky.1995.329">Terespolsky D, Farrell SA, Siegel-Bartelt J, Weksberg R. Infantile lethal variant of Simpson-Golabi-Behmel syndrome associated with hydrops fetalis. <span><span class="ref-journal">Am J Med Genet. </span>1995;<span class="ref-vol">59</span>:329–33.</span> [<a href="/pubmed/8599356" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8599356</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.thomas.2012.2534">Thomas M, Enciso V, Stratton R, Shah S, Winder T, Tayeh M, Roeder E. Metastatic medulloblastoma in an adolescent with Simpson&#x02013;Golabi&#x02013;Behmel syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2012;<span class="ref-vol">158A</span>:2534–6.</span> [<a href="/pubmed/22893378" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22893378</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.vaisfeld.2017.285">Vaisfeld A, Pomponi MG, Pietrobono R, Tabolacci E, Neri G. Simpson&#x02013;Golabi&#x02013;Behmel syndrome in a female: a case report and an unsolved issue. <span><span class="ref-journal">Am J Med Genet. </span>2017;<span class="ref-vol">173</span>:285–8.</span> [<a href="/pubmed/27739211" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27739211</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.veugelers.2000.1321">Veugelers M, Cat BD, Muyldermans SY, Reekmans G, Delande N, Frints S, Legius E, Fryns JP, Schrander-Stumpel C, Weidle B, Magdalena N, David G. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. <span><span class="ref-journal">Hum Mol Genet. </span>2000;<span class="ref-vol">9</span>:1321–8.</span> [<a href="/pubmed/10814714" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10814714</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.veugelers.1998.1">Veugelers M, Vermeesch J, Watanabe K, Yamaguchi Y, Marynen P, David G. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome. <span><span class="ref-journal">Genomics. </span>1998;<span class="ref-vol">53</span>:1–11.</span> [<a href="/pubmed/9787072" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9787072</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.vuillaume.2018.790">Vuillaume M-L, Moizard M-P, Rossignol S, Cottereau E, Vonwill S, Alessandri J-L, Busa T, Colin E, Gerard M, Biuliano F, Lambert L, Lefevre M, Kotecha U, Nampoothiri S, Netchine I, Raynaud M, Bioude F, Toutain A. Mutation update for the GPC3 gene involved in Simpson-Golabi-Behmel syndrome and review of the literature. <span><span class="ref-journal">Hum Mutat. </span>2018;<span class="ref-vol">39</span>:790–805.</span> [<a href="/pubmed/29637653" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29637653</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.waterson.2010.3179">Waterson J, Stockley TL, Segal S, Golabi M. Novel duplication in glypican-4 as an apparent cause of Simpson-Golabi-Behmel syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2010;<span class="ref-vol">152A</span>:3179–81.</span> [<a href="/pubmed/21082656" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21082656</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.williamson.1970.145">Williamson DA. A syndrome of congenital malformations possibly due to maternal diabetes. <span><span class="ref-journal">Dev Med Child Neurol. </span>1970;<span class="ref-vol">12</span>:145–52.</span> [<a href="/pubmed/5418989" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5418989</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.yano.2011.466">Yano S, Baskin B, Bagheri A, Watanabe Y, Moseley K, Nishimura A, Matsumoto N, Ray PN. Familial Simpson-Golabi-Behmel syndrome: studies of X-chromosome inactivation and clinical phenotypes in two female individuals with GPC3 mutations. <span><span class="ref-journal">Clin Genet. </span>2011;<span class="ref-vol">80</span>:466–71.</span> [<a href="/pubmed/20950395" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20950395</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sgbs.REF.young.2006.139">Young EL, Wishnow R, Nigro MA. Expanding the clinical picture of Simpson-Golabi-Behmel syndrome. <span><span class="ref-journal">Pediatr Neurol. </span>2006;<span class="ref-vol">34</span>:139–42.</span> [<a href="/pubmed/16458828" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16458828</span></a>]</div></li></ul></div></div><div id="sgbs.Chapter_Notes"><h2 id="_sgbs_Chapter_Notes_">Chapter Notes</h2><div id="sgbs.Author_Notes"><h3>Author Notes</h3><p>Mr Hathaway is a licensed genetic counselor.</p><p>Dr Kalish is board certified in pediatrics and clinical genetics and is an Assistant Professor of Pediatrics and Genetics.</p></div><div id="sgbs.Author_History"><h3>Author History</h3><p>Kathy Culver, MS; California Pacific Medical Center (2006-2011)<br />Mahin Golabi, MD, MPH; California Pacific Medical Center (2006-2018)<br />Christina X Gonzalez-Gandolfi, BA (2018-present)<br />Evan R Hathaway, MS, LCGC (2018-present)<br />Aaron James; University of California San Francisco (2006-2011)<br />Jennifer M Kalish, MD, PhD (2018-present)<br />Alva Leung, BS; California Pacific Medical Center (2011-2018)<br />Christina Lopez, BS; California Pacific Medical Center (2011-2018)<br />Brian J Sajorda, BA (2018-present)</p></div><div id="sgbs.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>29 November 2018 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 June 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 December 2006 (me) Review posted live</div></li><li class="half_rhythm"><div>6 July 2006 (kc) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1219</span><span class="label">PMID: <a href="/pubmed/20301398" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301398</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/rss/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/stsl/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1219&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1219/?report=reader">PubReader</a></li><li><a href="/books/NBK1219/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1219" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1219" style="display:none" title="Cite this Page"><div class="bk_tt">Sajorda BJ, Gonzalez-Gandolfi CX, Hathaway ER, et al. Simpson-Golabi-Behmel Syndrome Type 1. 2006 Dec 19 [Updated 2018 Nov 29]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1219/pdf/Bookshelf_NBK1219.pdf">PDF version of this page</a> (510K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#sgbs.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#sgbs.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#sgbs.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#sgbs.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#sgbs.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#sgbs.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#sgbs.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#sgbs.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#sgbs.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#sgbs.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#sgbs.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2719[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GPC3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2239[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GPC4</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1473752" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1473752" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1473752" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1473752" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31145570" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Apert Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Apert Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wenger TL, Hing AV, Evans KN. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24006547" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lichter-Konecki U, Caldovic L, Morizono H, Simpson K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30048822" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Duplications of GPC3 and GPC4 genes in symptomatic female carriers of Simpson-Golabi-Behmel syndrome type 1.</a><span class="source">[Eur J Med Genet. 2019]</span><div class="brieflinkpop offscreen_noflow">Duplications of GPC3 and GPC4 genes in symptomatic female carriers of Simpson-Golabi-Behmel syndrome type 1.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schirwani S, Novelli A, Digilio MC, Bourn D, Wilson V, Roberts C, Dallapiccola B, Hobson E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Med Genet. 2019 Apr; 62(4):243-247. Epub 2018 Jul 23.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301451" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type II</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type II<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Scarpa M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301568" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beckwith-Wiedemann Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beckwith-Wiedemann Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shuman C, Beckwith JB, Weksberg R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301398" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301398" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc8b1239a66ee2ba17bccd">Simpson-Golabi-Behmel Syndrome Type 1 - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Simpson-Golabi-Behmel Syndrome Type 1 - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T03:49:22-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE8915F8DFC87B210000000001A700D2&amp;ncbi_session=CE8915F8DFC8B111_0423SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1219%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1219&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1219/&amp;ncbi_pagename=Simpson-Golabi-Behmel Syndrome Type 1 - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8915F8DFC8B111_0423SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>